Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
he received dose one of SHINGRIX in 2019 and has not yet had the 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose in 2019). On an unknown date, the patient did not receive the 2nd dose of Shingrix. The patient had incomplete course of vaccination (Verbatim: he received dose one of SHINGRIX in 2019 and has not yet had the 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 21-JUL-2025 The reporter was an older male who stated that he received dose one of Shingrix in 2019 and had not yet had the 2nd dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix which led to incomplete course of vaccination. This case US2025AMR094554 was reporter by same reporter.; Sender's Comments: US-GSK-US2025AMR094554:Same reporter,different patient